"Pancreatic exocrine insufficiency (PEI) secondary to chronic use of long-acting (LA) somatostatin analogues (SSA) in pts with neuroendocrine tumors (NETs): Pooled analysis (USA and UK)."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Pancreatic exocrine insufficiency (PEI) secondary to chronic use of long-acting (LA) somatostatin analogues (SSA) in pts with neuroendocrine tumors (NETs): Pooled analysis (USA and UK).

e16166Background: SSAs are the most common treatment for well-differentiated NETs. Side effects include biliary and GI disorders, injection-site pain and hyperglycemia. There is often misdiagnosis ... Click to show full abstract

Keywords: chronic use; insufficiency pei; secondary chronic; pancreatic exocrine; pei secondary; exocrine insufficiency

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
2

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended